Access funding
Our funding streams can help you develop your research, share your innovations and build a business that can have real-world impact on patients.
All companies start with an idea.
We can help you learn how to transform your early-stage idea into a start-up. You bring the ideas. We'll provide resources and knowledge to help you on your entrepreneurial journey.
Discover our business accelerator programmes.
Find out more about each of these programmes below or contact us to find out about other ways we can help.
Panacea Stars - Develop Programme
What: Generate a wider impact, develop entrepreneurial skills, build a team and turn your research into a data-driven business. This programme is open to cancer researchers across the UK, in partnership with the University of Edinburgh and Edinburgh Innovations.
Who: Postgraduate students and researchers
When: Applications for 2024-25 cohort have currently closed. To apply to this 4 month programme for the 2025-26 cohort, please continue to check our website for application deadline updates.
What: Whet your entrepreneurial appetite and develop your vision with OncoStars' engagement, training, and translation platform for cancer researchers.
All stages or research ideas are welcome from idea to proof-of-concept.
Who: All cancer researchers working in detection, prevention, treatment, both as teams or single founders. Cancer Research UK funding not essential.
When: Programme runs for 3-8 months. The 2024 cohort is currently ongoing. To apply to the 2025 cohort, please continue to checkout our website for application deadline updates.
What: Challenge your ideas while refining your business offering and sharpening your commercial skills.
Who: Full-time or part-time founder(s) with an early-stage idea supported by preliminary data and/or sound proposal and a provisional or in-development business plan
When: Applications are currently open with a deadline of 21 October 2024. The programme runs for eight weeks.
What: The programme is delivered in partnership with Capital Enterprise, Cancer Research UK, the Brain Tumour Charity, Blood Cancer UK, LifeArc and HGF with support from Roche. The six strongest teams will each be awarded £70,000 of non-dilutive grant funding and six months of tailored mentoring, to develop your concept, form a start-up, and gain all the tools to successfully bring your healthtech to market.
Who: For cancer researchers developing early-stage technologies relying on data, AI or MedTech to advance cancer detection, diagnosis, monitoring, or treatment.
When: The programme runs for nine months. To apply to the 2025 programme, please continue to checkout our website for application deadline updates.
What: Designed to cater to the unique needs of early stage life science companies from across the UK, the programme offers six months of free laboratory space at Alderley Park, comprehensive support and specialist facilities to fuel your growth and development.
Who: Open to early stage and growing life science businesses
When: Programme runs for six months. Applications for the current 2024-25 cohort are closed. To apply to the next cohort, please continue to check our website for application deadline updates.
What: This accelerator programme helps start-ups to transform healthcare through data-driven solutions. To participate in the KQ labs accelerator, as a Cancer Research Horizons sponsored company, you must be an early-stage oncology healthcare-focused company using data as a core part of your business model.
Who: For UK-based early-stage companies with a team of two or more and a minimum viable product, prototype or proof of concept.
When: The programme runs for five months. Applications for the 2024-25 cohort have just closed. To apply to the 2025-26 cohort, please continue to checkout our website for application deadline updates.
We can identify the right entrepreneurial support for you.